TrialBMC infectious diseases2017

Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.

Myra W Popejoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.